Fellowship · New York, NY
Sponsored by Icahn School of Medicine at Mount Sinai
Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.
The Journal of allergy and clinical immunology · 2021 · 90 citations · John Nia, Peter Hashim
Assessing the accuracy, usefulness, and readability of artificial-intelligence-generated responses to common dermatologic surgery questions for patient education: A double-blinded comparative study of ChatGPT and Google Bard.
Journal of the American Academy of Dermatology · 2024 · 23 citations · Jesse Lewin
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.
Archives of dermatological research · 2023 · 33 citations · John Nia, Peter Hashim
Single-cell spatial transcriptomic analysis of human skin anatomy.
Nature genetics · 2026 · 6 citations · Jesse Lewin
Alopecia areata after SARS-CoV-2 vaccination.
JAAD case reports · 2022 · 35 citations · Alyssa Breneman
Secukinumab maintains superiority over ustekinumab in clearing skin and improving quality of life in patients with moderate to severe plaque psoriasis: 52-week results from a double-blind phase 3b trial (CLARITY).
Journal of the European Academy of Dermatology and Venereology : JEADV · 2021 · 38 citations · John Nia, Peter Hashim
Emerging off-label esthetic uses of botulinum toxin in dermatology.
Dermatologic therapy · 2022 · 19 citations · Hooman Khorasani
Evaluation of large language model responses to Mohs surgery preoperative questions.
Archives of dermatological research · 2024 · 7 citations · Alyssa Breneman, Courtney Ensslin